Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
15/10/2024 12:00
Oct 15 (Reuters) - H Lundbeck A/S HLUNb.CO :
* LONGBOARD PHARMACEUTICALS: IF DEAL IS TERMINATED UNDER
SOME
CIRCUMSTANCES, CO REQUIRED TO PAY H. LUNDBECK A/S TERMINATION
FEE OF $86.1 MILLION
* LONGBOARD PHARMACEUTICALS: UNDER AGREEMENT H. LUNDBECK
REQUIRED
TO PAY CO REVERSE TERMINATION FEE OF $158.9 MILLION IN CASH
UNDER CERTAIN CIRCUMSTANCE
Source text for Eikon: ID:n0001193125-24-237160
Further company coverage: HLUNb.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Longboard Pharmaceuticals
See all newsBrief: Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin In Developmental And Epileptic Encephalopathies (DEEs)
Longboard Pharmaceuticals Inc expected to post a loss of 62 cents a share - Earnings Preview
Brief: Longboard Pharmaceuticals Under Agreement H Lundbeck Required To Pay Co Reverse Termination Fee Of $158.9 Mln In Cash
U.S. RESEARCH ROUNDUP- Cadence Design Systems, Equity Bancshares, S&P Global
Deals of the day-Mergers and acquisitions